PreludeDx was founded to deliver actionable tools to manage early stage breast cancer.
PreludeDx's first diagnostic test, DCISionRT is the result of over a decade of research and development focused on DCIS. PreludeDx began developing its DCIS test in 2009 after licensing technology from University of California, San Francisco. DCISionRT’s technology was designed from the beginning to address the critical question faced by patients with DCIS. What is my risk of recurrence and what treatment is appropriate?
Company Details
- Employees
- 78
- Address
- 26051 Merit Circle,
- Phone
- (888) 211-3247
- in****@****edx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- preludedx.com
- Keywords
- Representative jobs.
- HQ
- Laguna Hills, CA
Preludedx Questions
Preludedx's helpline number is (888) 211-3247
Preludedx's website is preludedx.com
Preludedx's LinkedIn profile is https://www.linkedin.com/company/preludedx
Preludedx has
78 employees.
View email and phone details for 78
employees at Preludedx.
Preludedx's industry is
Biotechnology Research
Preludedx's top competitors are
Neogenomics Laboratories,
Nrichdx,
Ambry Genetics,
Hologic, Inc.,
Guardant Health,
Mdxhealth,
Genedx,
Exact Sciences,
Natera,
Agendia.
Preludedx's support email address is info@preludedx.com
Preludedx's categories are Biotechnology Research
